
|Articles|March 20, 2008
DigiFab production increased to combat temporary antibody shortage
Fougera and Protherics announce increased DigiFab production to counteract shortage.
Advertisement
Fougera and Protherics, Inc. have announced an increase in production of their digoxin immune fab (ovine) (
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
TrumpRx Officially Launches, Introduces Drug Prices
2
President Trump Signs Sweeping, Unprecedented Federal PBM Reform
3
As Immunization Schedules Change, Vaccine Confidence Among Patients Falters
4
Q&A: PBMs, Community Pharmacy’s Next Move Following PBM Reform Signing
5























